These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28256955)

  • 1. Preconception genetic carrier screening: use and problems.
    Wiwanitkit V
    Ups J Med Sci; 2017 Mar; 122(1):67. PubMed ID: 28256955
    [No Abstract]   [Full Text] [Related]  

  • 2. Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives.
    Traeger-Synodinos J; Harteveld CL
    Expert Rev Mol Diagn; 2017 Mar; 17(3):281-291. PubMed ID: 28110577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for carriers of cystic fibrosis. Screening before pregnancy is needed.
    Raeburn JA
    BMJ; 1994 Nov; 309(6966):1428-9. PubMed ID: 7819857
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and genetic diagnosis of haemoglobin disorders.
    Old JM
    Blood Rev; 2003 Mar; 17(1):43-53. PubMed ID: 12490210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing.
    Trent RJ; Webster B; Bowden DK; Gilbert A; Holl PJ; Lindeman R; Lammi A; Rowell J; Hinchcliffe M; Colley A; Wilson M; Saleh M; Blackwell J; Petrou V
    Pathology; 2006 Dec; 38(6):507-19. PubMed ID: 17393977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Values and value conflicts in implementation and use of preconception expanded carrier screening - an expert interview study.
    Matar A; Hansson MG; Höglund AT
    BMC Med Ethics; 2019 Apr; 20(1):25. PubMed ID: 31014326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant haemoglobinopathies: guidelines for screening and diagnosis.
    Ryan K; Bain BJ; Worthington D; James J; Plews D; Mason A; Roper D; Rees DC; de la Salle B; Streetly A;
    Br J Haematol; 2010 Apr; 149(1):35-49. PubMed ID: 20067565
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical quandaries around expanded carrier screening in third-party reproduction.
    Mertes H; Lindheim SR; Pennings G
    Fertil Steril; 2018 Feb; 109(2):190-194. PubMed ID: 29447661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth.
    Hardy MW; Kener HJ; Grinzaid KA
    Public Health Genomics; 2018; 21(1-2):67-76. PubMed ID: 30408784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing.
    Kauffman TL; Wilfond BS; Jarvik GP; Leo MC; Lynch FL; Reiss JA; Richards CS; McMullen C; Nickerson D; Dorschner MO; Goddard KA
    Contemp Clin Trials; 2017 Feb; 53():100-105. PubMed ID: 27940182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded carrier screening: what the reproductive endocrinologist needs to know.
    Dungan J
    Fertil Steril; 2018 Feb; 109(2):183-189. PubMed ID: 29447660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners.
    Delatycki MB; Laing NG; Moore SJ; Emery J; Archibald AD; Massie J; Kirk EP
    Aust J Gen Pract; 2019 Mar; 48(3):106-110. PubMed ID: 31256466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter validation of fully automated capillary electrophoresis method for diagnosis of thalassemias and hemoglobinopathies in Thailand.
    Sangkitporn S; Sangkitporn SK; Tanjatham S; Suwannakan B; Rithapirom S; Yodtup C; Yowang A; Duangruang S
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1224-32. PubMed ID: 22299449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded carrier screening: A current perspective.
    Mastantuoni E; Saccone G; Al-Kouatly HB; Paternoster M; D'Alessandro P; Arduino B; Carbone L; Esposito G; Raffone A; De Vivo V; Maruotti GM; Berghella V; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():41-54. PubMed ID: 30240948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization on laboratory diagnosis of thalassemia and abnormal hemoglobin.
    Fucharoen S; Winichagoon P; Piankijagum A
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():90-8. PubMed ID: 10926267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular biology completes clinical chemical methods in investigation of hemoglobin diseases].
    Landin B; Jeppsson JO
    Lakartidningen; 1992 Sep; 89(39):3147-8. PubMed ID: 1405918
    [No Abstract]   [Full Text] [Related]  

  • 18. Turkish female immigrants' intentions to participate in preconception carrier screening for hemoglobinopathies in the Netherlands: an empirical study.
    van Elderen T; Mutlu D; Karstanje J; Passchier J; Tibben A; Duivenvoorden HJ
    Public Health Genomics; 2010; 13(7-8):415-23. PubMed ID: 20805680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic assessment using capillary electrophoresis system.
    Srivorakun H; Fucharoen G; Changtrakul Y; Komwilaisak P; Fucharoen S
    Clin Biochem; 2011 Apr; 44(5-6):406-11. PubMed ID: 21277293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the haemoglobinopathies.
    Modell B
    Br Med Bull; 1983 Oct; 39(4):386-91. PubMed ID: 6357347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.